Trial Profile
Pramipexole Special Survey on Long-Term Use.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2014
Price :
$35
*
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 24 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2009 Actual patient number (1645) added as reported by ClinicalTrials.gov.
- 24 Jun 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.